LLY logo

Eli Lilly and Company (LLY) Free cash flow

annual FCF:

$414.30M+$3.57B(+113.14%)
December 31, 2024

Summary

  • As of today (April 12, 2025), LLY annual free cash flow is $414.30 million, with the most recent change of +$3.57 billion (+113.14%) on December 31, 2024.
  • During the last 3 years, LLY annual FCF has fallen by -$4.97 billion (-92.31%).
  • LLY annual FCF is now -93.35% below its all-time high of $6.23 billion, reached on December 31, 2008.

Performance

LLY Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYcash flow metrics

quarterly FCF:

$726.60M+$1.19B(+258.34%)
December 31, 2024

Summary

  • As of today (April 12, 2025), LLY quarterly free cash flow is $726.60 million, with the most recent change of +$1.19 billion (+258.34%) on December 31, 2024.
  • Over the past year, LLY quarterly FCF has stayed the same.
  • LLY quarterly FCF is now -65.48% below its all-time high of $2.10 billion, reached on December 31, 2008.

Performance

LLY quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYcash flow metrics

TTM FCF:

$414.30M+$2.69B(+118.21%)
December 31, 2024

Summary

  • As of today (April 12, 2025), LLY TTM free cash flow is $414.30 million, with the most recent change of +$2.69 billion (+118.21%) on December 31, 2024.
  • Over the past year, LLY TTM FCF has stayed the same.
  • LLY TTM FCF is now -93.35% below its all-time high of $6.23 billion, reached on December 31, 2008.

Performance

LLY TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

LLY Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+113.1%0.0%0.0%
3 y3 years-92.3%-12.2%-89.1%
5 y5 years-88.1%-12.2%-89.1%

LLY Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-92.3%+113.1%-55.8%+137.0%-92.9%+110.6%
5 y5-year-92.3%+113.1%-63.2%+137.0%-92.9%+110.6%
alltimeall time-93.3%+113.1%-65.5%+137.0%-93.3%+110.6%

Eli Lilly and Company Free cash flow History

DateAnnualQuarterlyTTM
Dec 2024
$414.30M(-113.1%)
$726.60M(-258.3%)
$414.30M(-118.2%)
Sep 2024
-
-$458.90M(-823.8%)
-$2.28B(-37.3%)
Jun 2024
-
$63.40M(-23.8%)
-$3.63B(-6.9%)
Mar 2024
-
$83.20M(-104.2%)
-$3.90B(+23.6%)
Dec 2023
-$3.15B(-168.5%)
-$1.96B(+8.4%)
-$3.15B(+1811.5%)
Sep 2023
-
-$1.81B(+786.4%)
-$164.90M(-105.1%)
Jun 2023
-
-$204.40M(-124.7%)
$3.21B(-15.2%)
Mar 2023
-
$827.10M(-19.2%)
$3.79B(-17.7%)
Dec 2022
$4.60B(-14.6%)
$1.02B(-34.5%)
$4.60B(-13.8%)
Sep 2022
-
$1.56B(+323.2%)
$5.34B(+7.9%)
Jun 2022
-
$369.70M(-77.5%)
$4.95B(-15.0%)
Mar 2022
-
$1.64B(-6.8%)
$5.82B(+8.1%)
Dec 2021
$5.39B(+20.5%)
$1.76B(+49.9%)
$5.39B(+16.6%)
Sep 2021
-
$1.18B(-5.5%)
$4.62B(-4.5%)
Jun 2021
-
$1.24B(+3.2%)
$4.84B(-13.1%)
Mar 2021
-
$1.21B(+21.1%)
$5.56B(+24.5%)
Dec 2020
$4.47B(+28.3%)
$995.70M(-28.4%)
$4.47B(-12.5%)
Sep 2020
-
$1.39B(-29.4%)
$5.11B(+4.6%)
Jun 2020
-
$1.97B(+1675.2%)
$4.89B(+32.7%)
Mar 2020
-
$111.10M(-93.2%)
$3.68B(+5.8%)
Dec 2019
$3.48B(+39.0%)
$1.64B(+40.1%)
$3.48B(+30.4%)
Sep 2019
-
$1.17B(+52.6%)
$2.67B(-19.6%)
Jun 2019
-
$766.20M(-958.0%)
$3.32B(+49.9%)
Mar 2019
-
-$89.30M(-110.8%)
$2.22B(-11.5%)
Dec 2018
$2.51B(-27.4%)
$825.00M(-54.7%)
$2.51B(-14.5%)
Sep 2018
-
$1.82B(-634.8%)
$2.93B(+15.3%)
Jun 2018
-
-$340.70M(-270.4%)
$2.54B(-41.0%)
Mar 2018
-
$200.00M(-84.0%)
$4.31B(+24.9%)
Dec 2017
$3.45B(-8.2%)
$1.25B(-12.8%)
$3.45B(-7.8%)
Sep 2017
-
$1.43B(+0.3%)
$3.74B(-0.0%)
Jun 2017
-
$1.43B(-316.3%)
$3.74B(+7.9%)
Mar 2017
-
-$660.90M(-142.9%)
$3.47B(-7.6%)
Dec 2016
$3.76B(+180.9%)
$1.54B(+7.5%)
$3.76B(+41.4%)
Sep 2016
-
$1.43B(+24.0%)
$2.66B(+32.5%)
Jun 2016
-
$1.16B(-409.7%)
$2.01B(+39.5%)
Mar 2016
-
-$373.40M(-184.5%)
$1.44B(+7.5%)
Dec 2015
$1.34B(-53.7%)
$441.90M(-43.4%)
$1.34B(-14.8%)
Sep 2015
-
$781.20M(+32.7%)
$1.57B(-26.6%)
Jun 2015
-
$588.70M(-224.4%)
$2.14B(-9.0%)
Mar 2015
-
-$473.40M(-170.3%)
$2.35B(-18.8%)
Dec 2014
$2.89B(-37.7%)
$673.80M(-50.1%)
$2.89B(-14.9%)
Sep 2014
-
$1.35B(+68.9%)
$3.40B(-10.3%)
Jun 2014
-
$799.00M(+1036.6%)
$3.79B(-15.6%)
Mar 2014
-
$70.30M(-94.1%)
$4.49B(-3.3%)
Dec 2013
$4.64B(+8.9%)
$1.18B(-32.0%)
$4.64B(+0.6%)
Sep 2013
-
$1.74B(+15.8%)
$4.61B(+9.7%)
Jun 2013
-
$1.50B(+577.6%)
$4.20B(+10.8%)
Mar 2013
-
$221.50M(-80.8%)
$3.79B(-11.0%)
Dec 2012
$4.26B(-23.1%)
$1.15B(-13.3%)
$4.26B(-10.7%)
Sep 2012
-
$1.33B(+21.6%)
$4.77B(-7.7%)
Jun 2012
-
$1.09B(+58.7%)
$5.17B(-7.3%)
Mar 2012
-
$688.20M(-58.6%)
$5.57B(+0.6%)
Dec 2011
$5.54B(-2.3%)
$1.66B(-3.7%)
$5.54B(-5.0%)
Sep 2011
-
$1.72B(+15.1%)
$5.83B(+2.6%)
Jun 2011
-
$1.50B(+128.0%)
$5.68B(+2.5%)
Mar 2011
-
$657.10M(-66.4%)
$5.54B(-2.2%)
Dec 2010
$5.67B(+62.9%)
$1.95B(+24.0%)
$5.67B(+5.2%)
Sep 2010
-
$1.58B(+16.1%)
$5.39B(+9.0%)
Jun 2010
-
$1.36B(+73.4%)
$4.94B(+14.1%)
Mar 2010
-
$782.90M(-53.2%)
$4.33B(+24.5%)
Dec 2009
$3.48B(-44.1%)
$1.67B(+47.8%)
$3.48B(-11.1%)
Sep 2009
-
$1.13B(+51.6%)
$3.91B(-16.6%)
Jun 2009
-
$746.40M(-1180.2%)
$4.69B(-0.7%)
Mar 2009
-
-$69.10M(-103.3%)
$4.73B(-24.1%)
Dec 2008
$6.23B(+52.9%)
$2.10B(+10.2%)
$6.23B(+4.0%)
Sep 2008
-
$1.91B(+145.1%)
$5.98B(+13.2%)
Jun 2008
-
$779.50M(-45.5%)
$5.29B(+9.0%)
Mar 2008
-
$1.43B(-23.2%)
$4.85B(+19.1%)
Dec 2007
$4.07B
$1.86B(+53.4%)
$4.07B(+11.4%)
Sep 2007
-
$1.21B(+254.8%)
$3.66B(+9.4%)
DateAnnualQuarterlyTTM
Jun 2007
-
$342.30M(-47.5%)
$3.34B(-3.3%)
Mar 2007
-
$652.40M(-54.9%)
$3.46B(+19.3%)
Dec 2006
$2.90B(+370.9%)
$1.45B(+60.8%)
$2.90B(+57.1%)
Sep 2006
-
$900.30M(+97.3%)
$1.85B(+501.8%)
Jun 2006
-
$456.30M(+386.5%)
$306.60M(+109.0%)
Mar 2006
-
$93.80M(-76.2%)
$146.70M(-76.2%)
Dec 2005
$615.50M(-36.6%)
$394.70M(-161.8%)
$615.50M(+105.7%)
Sep 2005
-
-$638.20M(-315.3%)
$299.20M(-76.6%)
Jun 2005
-
$296.40M(-47.3%)
$1.28B(-9.8%)
Mar 2005
-
$562.60M(+617.6%)
$1.42B(+46.2%)
Dec 2004
$971.40M(-49.9%)
$78.40M(-77.2%)
$971.40M(-30.7%)
Sep 2004
-
$343.50M(-21.2%)
$1.40B(-19.4%)
Jun 2004
-
$436.10M(+284.6%)
$1.74B(-0.2%)
Mar 2004
-
$113.40M(-77.7%)
$1.74B(-10.2%)
Dec 2003
$1.94B(+106.4%)
$508.80M(-25.3%)
$1.94B(+11.8%)
Sep 2003
-
$680.70M(+54.6%)
$1.74B(+33.1%)
Jun 2003
-
$440.20M(+41.8%)
$1.30B(+8.2%)
Mar 2003
-
$310.40M(+2.1%)
$1.20B(+28.2%)
Dec 2002
$939.80M(-66.2%)
$304.10M(+22.1%)
$939.80M(-33.0%)
Sep 2002
-
$249.00M(-27.0%)
$1.40B(-28.4%)
Jun 2002
-
$341.20M(+649.9%)
$1.96B(-20.0%)
Mar 2002
-
$45.50M(-94.1%)
$2.45B(-11.8%)
Dec 2001
$2.78B(-9.0%)
$767.20M(-4.7%)
$2.78B(-2.4%)
Sep 2001
-
$805.40M(-3.1%)
$2.85B(-8.9%)
Jun 2001
-
$831.40M(+122.5%)
$3.12B(+6.7%)
Mar 2001
-
$373.60M(-55.3%)
$2.93B(-4.1%)
Dec 2000
$3.05B(+46.0%)
$835.00M(-22.9%)
$3.05B(+3.1%)
Sep 2000
-
$1.08B(+70.6%)
$2.96B(+1.3%)
Jun 2000
-
$635.10M(+27.0%)
$2.92B(+5.0%)
Mar 2000
-
$500.20M(-32.7%)
$2.79B(+33.2%)
Dec 1999
$2.09B(-5.4%)
$743.10M(-29.0%)
$2.09B(-7.0%)
Sep 1999
-
$1.05B(+111.1%)
$2.25B(+16.3%)
Jun 1999
-
$495.70M(-355.6%)
$1.93B(-5.1%)
Mar 1999
-
-$193.90M(-121.6%)
$2.04B(-7.9%)
Dec 1998
$2.21B(+8.6%)
$899.70M(+23.0%)
$2.21B(+4.4%)
Sep 1998
-
$731.60M(+22.1%)
$2.12B(+17.5%)
Jun 1998
-
$599.00M(-3036.3%)
$1.80B(+1.9%)
Mar 1998
-
-$20.40M(-102.5%)
$1.77B(-13.0%)
Dec 1997
$2.03B(+31.4%)
$806.40M(+93.6%)
$2.03B(+10.1%)
Sep 1997
-
$416.60M(-26.4%)
$1.85B(+3.6%)
Jun 1997
-
$566.10M(+131.1%)
$1.78B(+6.6%)
Mar 1997
-
$245.00M(-60.5%)
$1.67B(+8.1%)
Dec 1996
$1.55B(+21.5%)
$620.40M(+76.1%)
$1.55B(+0.8%)
Sep 1996
-
$352.30M(-22.6%)
$1.54B(+14.0%)
Jun 1996
-
$454.90M(+279.4%)
$1.35B(+11.7%)
Mar 1996
-
$119.90M(-80.3%)
$1.21B(-5.3%)
Dec 1995
$1.27B(+33.2%)
$608.40M(+271.4%)
$1.27B(+30.0%)
Sep 1995
-
$163.80M(-47.9%)
$979.50M(-19.8%)
Jun 1995
-
$314.20M(+68.1%)
$1.22B(+12.4%)
Mar 1995
-
$186.90M(-40.6%)
$1.09B(+13.7%)
Dec 1994
$955.80M(+8.2%)
$314.60M(-22.3%)
$955.80M(-0.1%)
Sep 1994
-
$405.00M(+125.0%)
$957.10M(+5.6%)
Jun 1994
-
$180.00M(+220.3%)
$906.30M(+0.4%)
Mar 1994
-
$56.20M(-82.2%)
$902.30M(+2.1%)
Dec 1993
$883.40M(+83.5%)
$315.90M(-10.8%)
$883.40M(+0.6%)
Sep 1993
-
$354.20M(+101.3%)
$878.10M(+36.4%)
Jun 1993
-
$176.00M(+371.8%)
$644.00M(+44.3%)
Mar 1993
-
$37.30M(-88.0%)
$446.40M(-7.3%)
Dec 1992
$481.40M(+329.1%)
$310.60M(+158.6%)
$481.40M(+75.6%)
Sep 1992
-
$120.10M(-656.0%)
$274.20M(-19.4%)
Jun 1992
-
-$21.60M(-129.9%)
$340.30M(+41.4%)
Mar 1992
-
$72.30M(-30.1%)
$240.60M(+114.4%)
Dec 1991
$112.20M(-76.0%)
$103.40M(-44.5%)
$112.20M(+190.7%)
Sep 1991
-
$186.20M(-253.5%)
$38.60M(-64.6%)
Jun 1991
-
-$121.30M(+116.2%)
$109.10M(-60.0%)
Mar 1991
-
-$56.10M(-288.3%)
$272.60M(-41.6%)
Dec 1990
$467.10M(-2.3%)
$29.80M(-88.4%)
$467.10M(+6.8%)
Sep 1990
-
$256.70M(+508.3%)
$437.30M(+142.1%)
Jun 1990
-
$42.20M(-69.5%)
$180.60M(+30.5%)
Mar 1990
-
$138.40M
$138.40M
Dec 1989
$478.10M
-
-

FAQ

  • What is Eli Lilly and Company annual free cash flow?
  • What is the all time high annual FCF for Eli Lilly and Company?
  • What is Eli Lilly and Company annual FCF year-on-year change?
  • What is Eli Lilly and Company quarterly free cash flow?
  • What is the all time high quarterly FCF for Eli Lilly and Company?
  • What is Eli Lilly and Company quarterly FCF year-on-year change?
  • What is Eli Lilly and Company TTM free cash flow?
  • What is the all time high TTM FCF for Eli Lilly and Company?
  • What is Eli Lilly and Company TTM FCF year-on-year change?

What is Eli Lilly and Company annual free cash flow?

The current annual FCF of LLY is $414.30M

What is the all time high annual FCF for Eli Lilly and Company?

Eli Lilly and Company all-time high annual free cash flow is $6.23B

What is Eli Lilly and Company annual FCF year-on-year change?

Over the past year, LLY annual free cash flow has changed by +$3.57B (+113.14%)

What is Eli Lilly and Company quarterly free cash flow?

The current quarterly FCF of LLY is $726.60M

What is the all time high quarterly FCF for Eli Lilly and Company?

Eli Lilly and Company all-time high quarterly free cash flow is $2.10B

What is Eli Lilly and Company quarterly FCF year-on-year change?

Over the past year, LLY quarterly free cash flow has changed by $0.00 (0.00%)

What is Eli Lilly and Company TTM free cash flow?

The current TTM FCF of LLY is $414.30M

What is the all time high TTM FCF for Eli Lilly and Company?

Eli Lilly and Company all-time high TTM free cash flow is $6.23B

What is Eli Lilly and Company TTM FCF year-on-year change?

Over the past year, LLY TTM free cash flow has changed by $0.00 (0.00%)
On this page